Taken together, our findings indicate that, while dysregulated IL-17a contributes to pathology in autoimmune diseases such as psoriasis or arthritis in humans, in canine leishmaniosis, IL-17a may serve a protective role in promoting an effective immune response. This evidence concerns the gene IL17A and arthritic joint disease.